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Abstract
Patients and non-specialist healthcare professionals are increasingly expected to understand and interpret the results of
genetic or genomic testing. These results are currently reported using a variety of templates, containing different amounts,
levels, and layouts of information. We set out to establish a set of recommendations for communicating genetic test results to
non-expert readers. We employed a qualitative-descriptive study design with user-centred design principles, including a
mixture of in-person semi-structured interviews and online questionnaires with patients, healthcare professionals and the
general public. The resulting recommendations and example template include providing at-a-glance comprehension of what
the test results mean for the patient; suggested next steps; and details of further information and support. Separation and
inclusion of technical methodological details enhances non-specialists’ understanding, while retaining important information
for specialists and the patients’ records. The recommendations address the high-level needs of patients and their non-
specialist clinicians when receiving genetic test results. These recommendations provide a solid foundation for the major
content and structure of reports, and we recommend further engagement with patients and clinicians to tailor reports to
speciﬁc types of test and results.
Introduction
Genetic and genomic testing is predicted to have a greatly
increased role in healthcare [1]. In practice this means that
such testing is increasingly likely to be ordered, and the
results interpreted, by non-specialist clinicians involved in
routine patient care. Under the broader directives of shared
decision-making and less paternalistic medicine, patients
themselves also have an increasing desire to receive and
understand detailed information about their unique genetic
make-up and its consequences for their lives. Genetic test
reports, therefore, need to be able to deliver the results and
their implications clearly and unambiguously to those who
have no training in genetics.
This is no small challenge. Even in the simple case of
genetic testing in clinical healthcare there are multiple
domains of uncertainty surrounding the result itself (e.g.
testing error) and what it actually means (e.g. variant sig-
niﬁcance). These challenges are exacerbated as more
genomic regions are tested, since a greater quantity of errors
will be induced (even for a low testing error-rate) and more
variants will be of ‘uncertain signiﬁcance’ as more clinically
uncertain loci of the genome are considered.
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This point has been recognised for some time now by
leading national governing bodies for genetics. As a result,
guidelines for genetic test reporting have been released by
the American College of Medical Genetics and Genomics
(ACMG) [2], European Society of Human Genetics
(ESHG) [3], and Association for Clinical Genetic Science
(ACGS) [4]. These guidelines are primarily concerned with
reporting the technical details associated with the testing
procedure and result interpretation. Importantly, they all
vary in their recommendations [5] and interpretation (see
O’Daniel et al. [6] for a US example) and are perpetually
revised as testing methodologies and the clinical relevance
of genetic variations become better understood. This results
in the need for extremely clear communication of exactly
what was tested and what the result means in every single
report so that non-specialists (and specialists alike) can
readily interpret reports without requiring contextual
knowledge of the reporting landscape at the time of testing
and from the location in which the report was generated.
The requirement for clear communication (including to non-
experts) is stated in the guidelines for all of the organisa-
tions listed above but isn’t explicitly elaborated on any
further. In fact, the practical guidance for ensuring this clear
communication of results is acknowledged to be minimal.
Review of existing knowledge
Efforts have been made to assess the communication of
results in reports from a variety of testing contexts for both
clinicians and patients, leading to the development of
communication guidelines and suggested report formats
(e.g. Lubin et al. [7] and Haga et al. [8]).
There are a few common themes. First, authors have
commented on the relevance of information contained
within reports. Joseph et al. [9] noted the discrepancies
between the information that genetic counsellors provided
to patients versus the information that the patients indicated
caring most about. Given that it is experts in genetics who
have traditionally decided the content and format of reports,
we identiﬁed this as likely to be an ongoing issue to be
addressed.
Stuckey et al. [10] found that parents in their study
continually searched for relevant information and resources
for their child’s genetic condition, but that current reporting
didn’t meet that need and led parents to extensive online
searching, with some admitting reticence relating to the
information that they found, and at least one saying that she
scared herself. Not all patients want more information,
though: Joseph et al. [9] described how one patient didn’t
want to know about information regarding the test, genetics,
or risk since they were factors beyond their control—only
the outcome was seen as meaningful. Williams et al. [11]
also looked at reporting from a patient perspective, identi-
fying that with the complex results of whole-genome
sequencing, some supportive interpretation information was
necessary to communicate potential clinical relevance to
their patient. They also appreciated that active clinical
guidance was given so that they could conﬁdently convey
this to the patient at the time of reading. The challenge for
reports is to provide information that is seen as relevant for
all parties, while being concise enough to not deter patients.
A second issue is the communication of the uncertainties
inherent in genetic tests and their results. These can be
classiﬁed into two kinds: genetic risk (the estimated chance
that a person will experience a given consequence) and
testing limitations (the chance that estimate is inaccurate).
Perceptions of genetic risk information have been shown to
be affected by individuals’ preconceptions of testing [12],
which can have its roots in familial and cultural back-
grounds [8]. While managing testing expectations is the role
of the genetic counsellor, there is considerable evidence in
the literature concerning risk communication strategies that
could be used to build a robust report template. A com-
prehensive review on this topic is provided in Lautenbach
et al. [13], which pools together the literature for genetic
risk communication with that of general medical risk. It
highlights important messages that are echoed throughout
the risk communication world: there is no one-size-ﬁts-all
approach and so multiple methods of communication
should be presented, positive and negative framing of risk
should both be given in order to avoid framing bias, and
pictographs can be used as effective methods of commu-
nicating percentages. Shaer et al. [14] empirically demon-
strated that visual presentations of genetic variant
information (regarding pathogenicity and clinical impor-
tance) to non-experts showed improved comprehension and
perceived comprehension when compared with traditional
tabular design formats. Adding the uncertainty resulting
from limitations to the testing accuracy compounds this
complex landscape of risk information but is necessary.
Both Dorschner et al. [15] and Kelman et al. [16] have
reported clinicians as wanting access to false positive and
false negative rates of tests for themselves and patients,
although it is uncertain from the literature whether patients
would ﬁnd this kind of information understandable and
useful, and it is seldom mentioned in current reports.
A third theme is the need for citations of scientiﬁc evi-
dence from which conclusions in the report derive, and
available resources for further information. In focus groups,
Cutting et al. [17] found clinicians wanted citations to the
academic literature that supports the interpretations stated in
the report. Johnson et al. [18], taking a more patient-centric
approach, found interviewees also wished to see additional
information about genomic testing, as well as the actions of
others in similar situations.
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Finally, unsurprisingly, the language used throughout the
report has been seen as critical to users’ understanding.
Studies have shown that non-experts prefer simpler lan-
guage [9, 11], with technical genetic terms creating confu-
sion and reluctance to even try to understand the content
[10]. Aside from this negative perception of technical lan-
guage, it has also been shown that there is a positive per-
ception of ‘simpler’ language. Lewis et al. [19] showed that
simpler language facilitated understanding and conﬁdence
to talk about results.
One theme with relatively little available evidence in
the literature is the graphic design and layout of reports.
This is interesting because there is a stark contrast
between the visual appearance of reports that have been
developed by, for example, direct-to-consumer (DTC)
genetic testing companies compared with those suggested
in the academic literature; the former tend to make more
use of colour and graphical elements to separate sections
of their reports when compared with the latter. It is likely
that these private companies have conducted testing
with their users that shows preference for graphics,
but that that data is proprietary. More data needs to be
gathered on this topic in the public domain when shifting
focus towards patients as recipients, since it may directly
increase comprehension [14].
In light of the limitations identiﬁed in this review of the
literature, and the lack of speciﬁc ofﬁcial guidance, we
undertook qualitative research with an objective of pro-
viding recommendations for making the content and struc-
ture of a genetic test report more accessible to patients and
non-specialist clinicians. To achieve this we undertook a
qualitative-descriptive study [20] aimed at eliciting the
requirements that our target audiences had. In particular we
adopted the user-centred design principle of involving end-
users in the design process and iterating based on their
feedback [21]. We started with semi-structured interviews
to elicit major themes, and followed this up with online
testing in a larger sample to verify our ﬁndings and elicit
further recommendations.
Semi-structured interviews: methods
This work was approved by the University of Cambridge
Psychology Research Ethics Committee. In August 2017,
semi-structured interviews lasting ~90 min were conducted
with a convenience sample (n= 9, 7 female, mean age 41,
SD= 12). Participants had varying relationships to genetic
testing. Four had experience as a patient, and ﬁve as health
professionals. Two participants additionally had experience
as patient advocates. Participants were interviewed about
their experience with genetic testing results and then asked
to comment on existing examples of genetic reports.
Example reports were collected to illustrate a wide
variety of approaches, including some from direct-to-
consumer genetic testing. Examples came from existing
genetic test reports and guidelines in current usage in the
UK, US and Europe to assess the range of different styles of
design, wording and length employed. These included
ACGS, ACMG, and ESHG guidelines and sample reports
[3, 22], as well as suggested reports in the literature from
Scheuner et al. [23], Dorschner et al. [15], Williams et al.
[11], and report examples from GeneDX, 23andme, Part-
ners Healthcare, and Lineagen.
The interviews were divided into two phases. Initially we
asked about participants’ experience with genetic reports in
their personal and professional capacities. In the second
phase we sought participants’ views on the example reports
addressing a number of prepared topics including the
overall visual impression and appropriateness of the length,
the level of the language and ease of understanding, the
‘actionability’ of the information given, and what degree of
trust the report engendered. In addition, we sought com-
ments from participants on a prototype outline based on our
review of the literature, which was iteratively updated based
on comments made in interviews.
Interviews were conducted by a combination of one or
more of three authors (HG, AF & GF) and notes were taken
during the interview. Audio was recorded for all interviews.
We adopted a descriptive qualitative approach [20] with
elements of a thematic analysis. Any comments from the
recordings that could form the basis of a recommendation
for a laboratory test report were transcribed. These com-
ments were then aggregated for all participants and an
initial code applied. Codes were then summarised into
themes. In applying a descriptive qualitative approach we
sought to produce a record of suggestions with minimal
interpretation.
Semi-structured interviews: results
We identiﬁed thirteen key recommendations, shown in
Table 1 (See Supplementary Materials for full list). Four of
these were made unanimously in all the interviews (where
n= 9).
The ﬁrst unanimous recommendation concerns the fact
that existing genetic test reports are very difﬁcult, if not
impossible, for patients and non-specialist clinicians to
understand. The main action required is the use of plain
language and the avoidance of jargon. The second concerns
the appearance and structure of the document itself. The
clarity and ﬂow of section headings can greatly enhance the
ease of reading and comprehension. Recommendation three
was to make the result of the test prominent in the report.
This means that the result of the test should stand out, and
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preferably be the ﬁrst thing the eye is drawn to. The ﬁnal
unanimous recommendation was to separate the technical
methodological details of the genetic test conducted from
the main message to be communicated to non-specialist
audiences.
The recommendations in Table 1 fall broadly into three
groupings. The ﬁrst of these is communication style which
captures a desire for plain language, the use of lay terms and
the avoidance of jargon where possible. Interviewees also
expressed a desire for a slightly more personal tone, for
example, using ‘your’ rather than ‘the proband’s’.
The content grouping addresses the key content that
patients and non-specialist clinicians seek in a report. The
three main sections are: ‘What the result means’, ‘What
actions should be taken’, and ‘where can further infor-
mation and support be found’. The ﬁrst section addresses
the interpretation of the test result, including its implica-
tions for diagnosis and prognosis. The second section
concerns actions to be taken, such as genetic counselling,
whether testing of relatives is recommended, and acces-
sing treatment. The ﬁnal section concerns the provision of
sources of further information and support. These include
links to information about any diagnosed conditions,
information about genetic counselling, information about
communicating results to family and employers, and
information on support that might be available, in parti-
cular peer support from other people similarly affected.
Providing trusted links to further information helps guide
patients towards trustworthy online information; patients
are otherwise likely to search for online guidance them-
selves, which can lead to distressing and misleading
information.
The structure and appearance grouping relates to the
design of the document. This is important not because it is
aesthetically pleasing but because it helps readers under-
stand the content of the document. Clear section headings
convey a useful hierarchy of information, documents that
ﬂow simply from top to bottom without large dense blocks
of text avoid overwhelming readers. These issues are par-
ticularly important given the sometimes immensely emotive
and stressful nature of obtaining and making sense of a
genetic test result.
The position of technical information concerning var-
iants and test methodology is important to consider. It was
clear that this information should be contained in a
patient-facing report, but that it should be clearly sepa-
rated in order to allow patients and non-specialists to
extract the key content they are looking for quickly and
unambiguously.
Many patients also reiterated that even a well-designed
report should certainly not take the place of a face-to-face
meeting in which the results are communicated by a
healthcare professional.Ta
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Online survey: methods
We generated two prototype designs (see Supplementary
Materials) incorporating the unanimous recommendations
from the interviews, but differing in the tone and the amount
of text they contained, and the presence or absence of a
graphic to convey risk. The difference between the reports
was designed to elicit comments on the extent that graphic
design features were desirable and acceptable. The reports
contained a pathogenic result for a ﬁctitious condition
‘Brendt Syndrome’ causing an increased risk in bowel
cancer. Page 1 of the report addressed the issues raised in
the interviews, and page 2 contained technical and metho-
dological details of the test.
With these prototype templates in place we sought fur-
ther feedback by asking participants to complete an online
survey rating different aspects of the reports. We recruited
28 patients (26 female, mean age 41, SD= 8), 29 non-
specialist clinicians (25 female, mean age 43, SD= 12) and
49 members of the general public (35 female, mean age 33,
SD= 10) to view our prototype reports and answer ques-
tions about them online. The patient group was recruited by
advertising via support groups and advocacy organisations.
Eighty-nine percent of these participants reported that they
or a family member had received a genetic test report. The
general public were recruited from proliﬁc.ac, an online
participant pool. Twenty percent of these participants
reported having received the results of a genetic test. In the
clinician group, 86% reported some professional experience
of receiving genetic test reports.
Participants rated the following statements on a seven-
point Likert scale: ‘I understand the results’; ‘I understand
the actions [the patient/I] could take’; ‘I understand how the
risk of developing cancer has changed’; ‘I would trust the
results are correct’; ‘The language used is appropriate’; ‘The
appearance of the report (colours, design) feels appropriate’;
‘I would want to see the technical information on Page 2’.
Free text ﬁelds in the survey also allowed participants to
comment on the forms under the following categories:
Questions you would still have; Trust in the result;
Appearance and structure of the report; Ease of ﬁnding
information; and Ease of comprehension. As with the
interviews, these data were analysed using a qualitative
description approach [20] with an abbreviated thematic
analysis. We ﬁrst coded each comment and then classiﬁed
these into themes.
Online survey: results
Ratings for the prototype with a risk depiction and more
graphic design features, were broadly similar to those for
the prototype with more text. For both, the large majority of
participants rated the reports favourably. This was true
across all of the features we probed, and was broadly similar
for patients, clinicians, and the general public. Participants’
Likert ratings of the graphic prototype are shown in Fig. 1.
The same pattern in ratings was observed for the text pro-
totype (see Supplementary Materials).
Table 2 lists 26 themes summarising a total of 478
initially coded comments. There were four broad groupings
of the themes. For the content themes, respondents mainly
wanted more information and detail on the topics that were
already present in the report. In particular, they wanted
more information on actionable next steps they could take.
Respondents also wanted more information about the syn-
drome itself. Respondents were in favour of using graphics
to explain and contextualise risk. Finally, respondents were
sensitive to ambiguity in the phrasing of the result, leading
to comments like ‘do I have it or not?’ and questions around
whether retesting would be needed.
On the design group of themes, the overwhelming
response was that people appreciated a document that was
simple to look at and navigate. This means a document that
ﬂows from top to bottom without columns or text boxes. It
also means clearly delineating sections and avoiding dense
blocks of text. The use of colour to differentiate sections of
the document was appreciated, but less so in the commu-
nication of the result. Respondents from all three groups
identiﬁed the grey box containing the result in one of the
reports as ‘foreboding’ and ‘sinister’.
The grouping of communication style themes reﬂected a
desire for lay terms and avoiding jargon. Many respondents
identiﬁed that the ﬁrst page was easy to understand and the
second (technical page) was very difﬁcult to understand.
Many respondents also identiﬁed that despite this they
would still like the technical details included in the report.
Of the two reports people preferred the tone of the ‘text’
version as it was felt to be more personal and less ‘brusque’.
On the ﬁnal grouping of trust, respondents commented
on the professional appearance of the document and the fact
that it was sourced by the UK’s National Health Service
(NHS). These comments reﬂect the fact that appearing
authoritative inspires trust. By contrast, some participants
determined their trust in the results by assessing the statis-
tical claims in the document. For example, respondents
identiﬁed the test sensitivity (99%) as a reason to trust the
result. Others found reason not to trust the result because the
technical section stated the variant had not previously been
found in that laboratory.
Overall recommendations
Table 3 shows a summary of recommendations for the high-
level content and structure of genetic reports suitable for
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patients and non-specialists that came out of our work. We
emphasise that such reports are not designed to replace a
face-to-face consultation between a patient and a healthcare
professional. These reports may improve the experience of
consultations and should be given to a patient as a take-
home, not sent before a consultation.
Figure 2 shows an example report applying some of the
recommendations. Much of the more detailed information
that participants wanted from reports pertains to condition-,
test- or result-speciﬁc scenarios. We therefore, as an over-
arching recommendation, suggest that the following should
be seen as a solid foundation upon which further con-
sultation with stakeholders can help identify the additional
detail that would be necessary (e.g. identifying appropriate
peer support groups, or testing how results should be wor-
ded for very different types of condition such as autism,
Huntington’s or raised cancer risks). When providing
information about support groups, it will be important that
these have passed some form of quality check. One
potential standard in the UK is Quality Mark currently
being piloted by the Patient Information Forum, and which
aims to help patients identify information they can trust.
These recommendations are in principle compliant with
ISO15189 [24]. However, report providers should check
that any ﬁnal report they develop is compliant with the
appropriate standards and regulations.
Discussion
There is clearly a need for an empirically-tested template for
genetic or genomic results that communicates equally well
to specialist and non-specialist clinicians and patients. A
review of the literature and existing reports suggested that
none currently existed, and that there were clear gaps in our
knowledge of what information, language and graphical
design was required to construct this.
We have developed a set of recommendations and an
example template that contains the major elements most
important to the patients, clinicians and specialists who
Clinicians Patients Public
U
nderstand
A
ctions
R
isk
Trust
Language
A
ppearance
Technical
−3 −2 −1 0 +1 +2 +3 −3 −2 −1 0 +1 +2 +3 −3 −2 −1 0 +1 +2 +3
0.0
0.2
0.4
0.6
0.0
0.2
0.4
0.6
0.0
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0.6
0.0
0.2
0.4
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0.0
0.2
0.4
0.6
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0.2
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0.6
0.0
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0.6
Answer
P
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Fig. 1 Participants’ ratings of
the ‘graphic’ prototype. The x
axis spans −3 (Completely
disagree) to +3 (Completely
agree) via 0 (Neither agree nor
disagree). Ratings for the other
prototype follow the same
pattern and are included in
the Supplementary Materials.
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receive reports. There was generally broad consensus within
each group as to what was important to them, and we
believe the recommendations can be implemented without
compromising the information required by each audience. It
should be noted that there was a bias toward female
volunteers in our sample, and although males did take part
at all stages, any future work implementing these recom-
mendations would beneﬁt from a more equal balance.
Our recommendations echo many ﬁndings from the
existing literature. In particular, we have created a ‘patient
friendly report’ [8] which has shown with appropriate lan-
guage that non-specialists perceive that they understand
results and know which actions they can take, addressing
concerns in Stuckey et al. [10], Williams et al. [11], and
Joseph et al. [9]. Risk was effectively communicated by
implementing recommended practice (raised in Lautenbach
et al. [13]), and our report uses favourable graphical design
while remaining appropriate (highlighted in Shaer et al.
[14], and apparent in direct-to-consumer reports). Finally,
we included necessary technical information and limitations
(as raised in Dorschner et al. [15] and Kelman et al. [16]).
This work, however, concentrated on the design of the
report template rather than the speciﬁc wording that it
would carry. There are many different types of genetic or
genomic test result—from diagnostic testing for patients
with a condition for which they are seeking a genetic
explanation, to incidental ﬁndings from a genomic test with
no relevant family history, and even polygenic risk scores.
This study also does not address whether or how to com-
municate more complex issues such as ﬁnding variants of
Table 2 Summary of themes derived from online comments and the number of endorsements from each participant group.
Group Theme Clinicians (n= 29) Patients
(n= 28)
Public
(n= 49)
Content Would want more information about topics addressed in report (family
implications, screening, treatment, next steps)
20 17 39
Content The use of simple diagrams and ﬁgures is helpful. Avoid unfamiliar
designs
11 13 15
Content Want more detailed information about syndrome/condition (e.g. prognosis,
prevalence)
5 6 9
Content Helpful to include separated technical section 5 5 4
Content Ambiguous wording of result unhelpful 4 0 2
Content Would like more information about the test statistics (sensitivity,
speciﬁcity etc.)
4 1 1
Content Technical section may cause fear or confusion 3 1 0
Content Include glossary to help with technical terms 0 2 0
Content Unhelpful to include technical section 2 0 0
Content Inclusion of patient details useful 0 1 0
Design Clearly labelled sections, white space, avoiding columns, and avoiding
dense blocks of text, all help with comprehension
24 22 45
Design The appropriate use of colour helps delineate sections, but avoid it in
communicating test result
12 12 26
Design Prominence of result helpful 2 4 2
Design Prominence of result alarming/stark 2 0 3
Design Use large enough font 1 0 1
Comm. Style Be concise and clear, with a personal tone, but avoid brevity at the expense
of important detail.
14 14 10
Comm. Style Patient section easy to understand, technical section is difﬁcult 11 6 7
Comm. Style Technical details difﬁcult to understand 6 5 12
Comm. Style Use lay language and avoid jargon 4 6 4
Comm. Style Make clear who the audience is for the technical section 2 0 0
Trust Trust of result based on technical aspects of test 7 4 5
Trust Trust result because sourced by NHS 4 0 12
Trust Trust of result based on appearance of document 6 0 4
Trust Trust if conﬁrmed by another test 1 1 2
Trust Trust result because signed 1 0 2
Trust Trust based on comprehension of report 0 0 2
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unknown signiﬁcance or when re-analysis of a sample leads
to new ﬁndings. Each of these types of testing scenario will
demand quite different wordings and explanations. For
example, some will be attempting to convey a possible
increased risk of an event with several layers of uncertainty
(purely aleatoric uncertainty which can be portrayed as a
probability; epistemic uncertainty about the strength and
quality of the evidence surrounding the inﬂuence of the
gene variant on future risk; uncertainty related to the sen-
sitivity and speciﬁcity of the test etc.), each needing quite a
different approach. This would be different from, say, a
carrier testing result where the gene variant has very high
penetrance and is well characterised so the communication
is mainly about the chances of inheritance in future
children.
To ascertain how best to illustrate and explain results in
the many complex reporting scenarios beyond the scope
of this research, it will be critical that the content and
formats of reports are carefully co-designed with their
target audiences. Following the design of this generic
template, we continued with development of wording and
further design reﬁnements, starting with templates for
carrier testing, and when formally assessed against report
forms in current clinical use proved clearer and more
actionable for patients (see Recchia et al.) [25]. This
article provides a framework for effective communication
of genetic test results. In addition, Recchia et al. [25]
provides a methodology for tailoring the framework to
more speciﬁc testing scenarios.
The process of iteratively engaging with recipients of
reports to produce this template and recommendations, is in
itself analogous to shared decision-making, a concept
becoming increasingly familiar in medicine. It involves a
dialogue with patients to ﬁnd out what is important to them
and come to a mutually-agreed solution that serves their
needs for clear and accurate information.
Providing patients, and their non-specialist healthcare
providers, with accurate and unambiguous test results arms
them with the information that they need to be able to take
part in shared decision-making. Where the results do not
need any further action, these forms should be able to give
clear reassurance without the need for input from genetic
specialists. When the results have implications that need full
discussion and decision-making, they can help ensure that
the patient is referred correctly to a suitably qualiﬁed pro-
fessional and give them the basic information they need to
take part in shared decision-making and informed consent
during that consultation.
In genetics, the unit of care is often the family rather
than just the individual, it is really important therefore
that genetic information be conveyed to other family
members accurately and having the patient understand the
information makes this much more likely to happen. Indeed
a number of interviewees identiﬁed that facilitating
Design, colour, clear
labelling and single
column text make form
easy to read
Patient's and sample
details on the top of
each page
Neutral, factual and
unambiguous wording
of result
Clear non-technical
language, addressed to
the patient
Graphics to help put
numbers into context.
Risks given with
appropriate comparison
and both positive &
negative framing
Full technical details
provided, clearly marked
as not necessary for the
patient to read
Sections on first page
presented in order:
Result – What it Means
 – Actions – Support
Fig. 2 An illustration of the recommendations in action. N.B. The NHS logo does not imply endorsement or funding of this work by the
National Health Service.
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communication with others would be a particularly desir-
able beneﬁt of a well-designed report. Although it is worth
noting that patients do not always wish to communicate
results to family members raising difﬁcult privacy and
consent issues (see section 4 in a recent report by the Joint
Committee on Genomics in Medicine [26] for a discussion).
By working across multiple audiences, and hand-in-
hand with those who need to implement any reports in
actual clinical practice, we have sought to develop a
practical and useful product which is ﬂexible enough to be
able to carry test results of many kinds, and will lead to
better-informed decision-making. We also hope to have
demonstrated more generally that involving the target
audience in the design of a communication is an efﬁcient
and valuable way to ensure effective communication of
important medical information.
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